GSK (MEX:GSKN) E10: MXN74.07 (As of Mar. 2026)


MEX:GSKN GSK PLC MEX:GSKN
73 GF Score
Price MXN901.11
GF Value MXN818.82
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is GSK E10?

GSK MEX:GSKN 73 E10 is MXN74.07 as of Mar. 2026. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GSK's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN20.485. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN74.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, GSK's average E10 Growth Rate was 13.10% per year. During the past 3 years, the average E10 Growth Rate was -1.80% per year. During the past 5 years, the average E10 Growth Rate was 5.30% per year. During the past 10 years, the average E10 Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of GSK was 12.20% per year. The lowest was -5.40% per year. And the median was 3.70% per year.

As of today (2026-06-24), GSK's current stock price is MXN901.11. GSK's E10 for the quarter that ended in Mar. 2026 was MXN74.07. GSK's Shiller PE Ratio of today is 12.17.

During the past 13 years, the highest Shiller PE Ratio of GSK was 17.38. The lowest was 8.38. And the median was 12.80.


GSK  (MEX:GSKN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GSK's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=901.11/74.07
=12.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of GSK was 17.38. The lowest was 8.38. And the median was 12.80.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GSK E10 Related Terms


GSK E10 Historical Data

* Premium members only.

The historical data trend for GSK's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK E10 Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.97 71.16 65.26 74.34 67.72

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.11 76.82 66.21 67.72 74.07

MEX:GSKN vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, GSK's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Shiller PE Ratio falls into.


MEX:GSKN
73GF Score
GSK PLC MEX:GSKN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GSK's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=20.485/140.8000*140.8000
=20.485

Current CPI (Mar. 2026) = 140.8000.

GSK Quarterly Data

per share eps CPI Adj_EPS
201606 -5.911 101.000 -8.240
201609 10.481 101.500 14.539
201612 3.346 102.200 4.610
201703 12.378 102.700 16.970
201706 -2.141 103.500 -2.913
201709 14.881 104.300 20.089
201712 -7.371 105.000 -9.884
201803 7.041 105.100 9.433
201806 5.814 105.900 7.730
201809 17.421 106.600 23.010
201812 15.161 107.100 19.932
201903 10.670 107.000 14.041
201906 11.747 107.900 15.329
201909 18.936 108.400 24.596
201912 16.005 108.500 20.770
202003 22.635 108.600 29.346
202006 32.500 108.800 42.059
202009 17.670 109.200 22.783
202012 8.957 109.400 11.528
202103 15.097 109.700 19.377
202106 19.264 111.400 24.348
202109 16.269 112.400 20.380
202112 10.025 114.700 12.306
202203 23.295 116.500 28.154
202206 8.166 120.500 9.542
202209 120.599 122.300 138.842
202212 17.335 125.300 19.479
202303 15.969 126.800 17.732
202306 17.187 129.400 18.701
202309 15.349 130.100 16.611
202312 3.653 130.500 3.941
202403 10.713 131.600 11.462
202406 13.286 133.000 14.065
202409 -0.729 133.500 -0.769
202412 5.273 135.100 5.495
202503 20.775 136.100 21.492
202506 17.935 138.400 18.246
202509 24.343 138.900 24.676
202512 7.520 139.900 7.568
202603 20.485 140.800 20.485

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN74.07 mean?
GSK (MEX:GSKN) has a E10 of MXN74.07 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on GSK and its competitors.
Is GSK's E10 too high?
GSK's current E10 is MXN74.07. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's E10 compare to LLY and JNJ?
GSK's E10 of MXN74.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on GSK and its competitors. GSK's current E10 is MXN74.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current E10 is MXN74.07. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For GSK (MEX:GSKN), the current E10 is MXN74.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (MEX:GSKN) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82. GuruFocus considers GSK to be Fairly Valued.

Key valuation signals for MEX:GSKN:

  • E10: MXN74.07
  • GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score

Get the complete analysis for MEX:GSKN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN901.11
Price
MXN818.82
GF Value